01 1Changzhou Pharmaceutical Factory
01 1RIVAROXABAN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-04-17
Pay. Date : 2020-03-10
DMF Number : 34436
Submission : 2019-12-26
Status : Active
Type : II
20
Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 34436.
Remarkably, this DMF maintains an Active status since its submission on December 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2020, and payment made on March 10, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
